Scott Bizily

All filings by Scott Bizily on record concern 4D Molecular Therapeutics, Inc. In total, 40 filings cover trades dated from 1 December 2022 to 16 September 2026.

On the market, this insider has only sold: 10 sales, €204k in total. No amount is published for 2 filings, which the totals therefore leave out. Outside the open market, there are 30 option exercises. 2026 to date brings no purchases and 6 sales.

The record was last updated on 22 September 2026 with an option exercise (€5,868) in 4D Molecular Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.